Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia And Metabolic Syndrome
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2010, Vol 17, Issue 4
Abstract
Introduction and Objective: The aim of this study was to evaluate the relationship between lower urinary tract symptoms (LUTS), benign prostatic hyperplasia, and metabolic syndrome. Methods: 381 patients, over 45 years, with metabolic syndrome were divided in 2 groups: group A – 310 patients with BHP (MetS+BPH) and, group B – 71 patients without BPH (MetS-BPH). Fasting concentrations of plasma glucose, HbA1c, serum lipides (total cholesterol, triglycerides, high-density lipoprotein HDL-C), insulin, and prostate-specific antigen (PSA) were measured under standardised conditions at baseline, 6 months and one year. IR (insulin resistance) was determinated using homeostasis model assessment (HOMA-IR). The presence of LUTS was assessed using the International Prostate Symptoms Score. The prostate gland volume was measured using transrectal ultrasound (prostate volume over 30 cm3 was considered prostatic hyperplasia). Results: Prevalence of severe LUTS was 14.8% (n=46) in BPH patients and 4.2% (n=3) patients without prostatic diseases (0.032). Prevalence of moderate LUTS was 74.2% (n=230) in BPH patients and 78.9% (n=56) patients without prostatic diseases (0.032). IPSS score correlated positively with age, BMI, triglycerides, HDL-cholestrol, and HbA1c. Conclusion: LUTS are frequent in metabolic syndrome patients with or without benign prostatic hyperplasia. In patients with all five components of MetS there was an increased prevalence of LUTS. Resulting from this study it is our reccomendation that patients with MetS need follow up/seek advice from an urological specialist as well.
Authors and Affiliations
Florin Rusu, Emilia Rusu, Gabriela Radulian, Georgiana Enache, Mariana Jinga, Viorel Jinga, Dan Mischianu
Keywords
Related Articles
- EP ID EP102677
- DOI -
- Views 151
- Downloads 0
HIGHLIGHTS FROM THE AMERICAN DIABETES ASSOCIATION 71ST SCIENTIFIC SESSIONS
PERIOPERATIVE NUTRITIONAL STATUS
Malnutrition is defined as the pathological state in which the nutritional intake is insufficient, excessive or ill-balanced and represents a frequent problem among hospitalized patients. The risk factors involved in the...
THE VALUE OF DIFFERENT ANTHROPOMETRIC VARIABLES IN ASSESSING CARDIOMETABOLIC RISK
Objective. To investigate which anthropometric parameter best correlates with modifications in blood glucose and blood pressure (BP). Material and method. 135 subjects were included in the study. We measured weight, heig...
HEPATIC FIBROSIS, MEASURED BY FIBROSCANIN A GROUP OF PATIENTS WITH OBESITY
Introduction. Hepatic steatosis is a reversible condition caused by accumulation of triglycerides in liver cells. Non-alcoholic fatty liver disease (NAFLD) can progress to advanced liver disease: fibrosis, cirrhosi...
Weight Gain With Insulin Therapy In Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs
Type 2 diabetes mellitus is a disease with progressive beta-cell decline and most patients will require insulin therapy to control their glycemic homeostasis. The aims of this study is to estimate the weight gain associa...